242 related articles for article (PubMed ID: 18276777)
1. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
McCandless EE; Piccio L; Woerner BM; Schmidt RE; Rubin JB; Cross AH; Klein RS
Am J Pathol; 2008 Mar; 172(3):799-808. PubMed ID: 18276777
[TBL] [Abstract][Full Text] [Related]
2. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis.
Moll NM; Cossoy MB; Fisher E; Staugaitis SM; Tucky BH; Rietsch AM; Chang A; Fox RJ; Trapp BD; Ransohoff RM
Arch Neurol; 2009 Jan; 66(1):44-53. PubMed ID: 19139298
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.
McCandless EE; Wang Q; Woerner BM; Harper JM; Klein RS
J Immunol; 2006 Dec; 177(11):8053-64. PubMed ID: 17114479
[TBL] [Abstract][Full Text] [Related]
4. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Man S; Tucky B; Cotleur A; Drazba J; Takeshita Y; Ransohoff RM
Sci Transl Med; 2012 Feb; 4(119):119ra14. PubMed ID: 22301555
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
7. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.
Cruz-Orengo L; Holman DW; Dorsey D; Zhou L; Zhang P; Wright M; McCandless EE; Patel JR; Luker GD; Littman DR; Russell JH; Klein RS
J Exp Med; 2011 Feb; 208(2):327-39. PubMed ID: 21300915
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
Liu KK; Dorovini-Zis K
J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis.
McCandless EE; Zhang B; Diamond MS; Klein RS
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11270-5. PubMed ID: 18678898
[TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
11. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
[TBL] [Abstract][Full Text] [Related]
12. Expression and Cellular Localization of CXCR4 and CXCL12 in Human Carotid Atherosclerotic Plaques.
Merckelbach S; van der Vorst EPC; Kallmayer M; Rischpler C; Burgkart R; Döring Y; de Borst GJ; Schwaiger M; Eckstein HH; Weber C; Pelisek J
Thromb Haemost; 2018 Jan; 118(1):195-206. PubMed ID: 29304539
[TBL] [Abstract][Full Text] [Related]
13. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
[TBL] [Abstract][Full Text] [Related]
14. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.
Van Der Voorn P; Tekstra J; Beelen RH; Tensen CP; Van Der Valk P; De Groot CJ
Am J Pathol; 1999 Jan; 154(1):45-51. PubMed ID: 9916917
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning-induced CXCL12 upregulation minimizes leukocyte infiltration after stroke in ischemia-tolerant mice.
Selvaraj UM; Ortega SB; Hu R; Gilchrist R; Kong X; Partin A; Plautz EJ; Klein RS; Gidday JM; Stowe AM
J Cereb Blood Flow Metab; 2017 Mar; 37(3):801-813. PubMed ID: 27006446
[TBL] [Abstract][Full Text] [Related]
16. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
18. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
[TBL] [Abstract][Full Text] [Related]
19. Pathological roles of the homeostatic chemokine CXCL12.
Janssens R; Struyf S; Proost P
Cytokine Growth Factor Rev; 2018 Dec; 44():51-68. PubMed ID: 30396776
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF promotes migration of human monocytes across the blood brain barrier.
Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
